GoodRx Holdings Inc
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
GDRX$3.65+4.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
| Year Ended December 31, | |||
|---|---|---|---|
| (in thousands, except per share amounts) | 2023 | 2022 | 2021 |
| Revenue | $750,265 | $766,554 | $745,424 |
| Costs and operating expenses: | |||
| Cost of revenue, exclusive of depreciation and amortization presented separately below | 66,925 | 65,079 | 46,716 |
| Product development and technology | 135,836 | 143,137 | 125,860 |
| Sales and marketing | 341,328 | 357,631 | 370,217 |
| General and administrative | 125,515 | 144,792 | 154,686 |
| Depreciation and amortization | 107,668 | 54,177 | 34,539 |
| Total costs and operating expenses | 777,272 | 764,816 | 732,018 |
| Operating (loss) income | (27,007) | 1,738 | 13,406 |
| Other expense, net: | |||
| Other expense | (4,008) | — | — |
| Interest income | 32,171 | 9,274 | 59 |
| Interest expense | (56,728) | (34,243) | (23,642) |
| Total other expense, net | (28,565) | (24,969) | (23,583) |
| Loss before income taxes | (55,572) | (23,231) | (10,177) |
| Income tax benefit (expense) | 46,704 | (9,597) | (15,077) |
| Net loss | $(8,868) | $(32,828) | $(25,254) |
| Loss per share: | |||
| Basic and diluted | $(0.02) | $(0.08) | $(0.06) |
| Weighted average shares used in computing loss per share: | |||
| Basic and diluted | 410,315 | 412,858 | 409,981 |
| Stock-based compensation included in costs and operating expenses: | |||
| Cost of revenue | $610 | $359 | $798 |
| Product development and technology | 30,096 | 35,190 | 35,090 |
| Sales and marketing | 20,311 | 21,036 | 20,645 |
| General and administrative | 53,803 | 63,649 | 103,929 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.